$HITC
Healthcare Integrated Technologies Inc. Stock $hitc

$hitc Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-K Financial Statement

#000149315222026689 Filed on September 23, 2022

Income Statement

Concept	2022 Q3	2022	2021 Q3
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$224.6K	$1.138M	$296.6K
YoY Change	-24.28%	-10.71%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.820K	$232.00	$2.280K
YoY Change	23.68%	-89.55%
% of Gross Profit
Operating Expenses	$227.4K	$1.138M	$298.9K
YoY Change	-23.91%	-10.71%
Operating Profit		-$1.138M
YoY Change		-10.71%
Interest Expense	$91.03K	$447.6K	$30.25K
YoY Change	200.93%	96.41%
% of Operating Profit
Other Income/Expense, Net		-$223.0K
YoY Change		23.6%
Pretax Income	-$136.4K	-$1.360M	-$255.5K
YoY Change	-46.63%	-6.85%
Income Tax
% Of Pretax Income
Net Earnings	-$136.4K	-$1.361M	-$255.5K
YoY Change	-46.63%	-6.46%
Net Earnings / Revenue
Basic Earnings Per Share		-$0.03
Diluted Earnings Per Share	-$3.080K	-$32.37K	-$6.608K
COMMON SHARES
Basic Shares Outstanding	42.30M shares	42.02M shares
Diluted Shares Outstanding		42.02M shares

Balance Sheet

Concept	2022 Q3	2022	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.050K	$0.00	$11.44K
YoY Change	-90.82%	-100.0%
Cash & Equivalents	$1.051K	$0.00	$11.44K
Short-Term Investments
Other Short-Term Assets	$36.62K	$40.00K	$37.58K
YoY Change	-2.55%	0.0%
Inventory
Prepaid Expenses	$36.62K		$37.58K
Receivables
Other Receivables
Total Short-Term Assets	$37.67K	$40.00K	$49.02K
YoY Change	-23.16%	-20.0%
LONG-TERM ASSETS
Property, Plant & Equipment		$0.00	$230.00
YoY Change
Goodwill
YoY Change
Intangibles	$688.4K		$440.9K
YoY Change	56.13%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$688.4K	$690.0K	$441.1K
YoY Change	56.04%	56.82%
TOTAL ASSETS
Total Short-Term Assets	$37.67K	$40.00K	$49.02K
Total Long-Term Assets	$688.4K	$690.0K	$441.1K
Total Assets	$726.0K	$730.0K	$490.2K
YoY Change	48.12%	48.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$119.7K	$390.0K	$332.6K
YoY Change	-64.01%	18.18%
Accrued Expenses	$1.909M	$1.910M	$1.264M
YoY Change	51.1%	51.59%
Deferred Revenue
YoY Change
Short-Term Debt	$325.0K	$330.0K	$325.0K
YoY Change	0.0%	0.0%
Long-Term Debt Due	$780.6K	$460.0K	$230.0K
YoY Change	239.39%	100.0%
Total Short-Term Liabilities	$3.154M	$3.150M	$2.259M
YoY Change	39.58%	39.38%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.154M	$3.150M	$2.259M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$3.154M	$3.150M	$2.259M
YoY Change	39.58%	39.38%
SHAREHOLDERS EQUITY
Retained Earnings	-$14.31M		-$12.95M
YoY Change	10.51%
Common Stock	$11.88M		$11.08M
YoY Change	7.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.428M	-$2.430M	-$1.769M
YoY Change
Total Liabilities & Shareholders Equity	$726.0K	$730.0K	$490.2K
YoY Change	48.12%	48.98%

Cashflow Statement

Concept	2022 Q3	2022	2021 Q3
OPERATING ACTIVITIES
Net Income	-$136.4K	-$1.361M	-$255.5K
YoY Change	-46.63%	-6.46%
Depreciation, Depletion And Amortization	$2.820K	$232.00	$2.280K
YoY Change	23.68%	-89.55%
Cash From Operating Activities	-$40.71K	-$212.2K	-$66.45K
YoY Change	-38.74%	-64.17%
INVESTING ACTIVITIES
Capital Expenditures	-$3.830K	-$30.00K	-$19.95K
YoY Change	-80.8%	-50.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$3.830K	-$32.69K	-$19.95K
YoY Change	-80.8%	-46.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	35.00K	$234.5K	47.50K
YoY Change	-26.32%	-60.0%
NET CHANGE
Cash From Operating Activities	-40.71K	-$212.2K	-66.45K
Cash From Investing Activities	-3.830K	-$32.69K	-19.95K
Cash From Financing Activities	35.00K	$234.5K	47.50K
Net Change In Cash	-9.540K	-$10.39K	-38.90K
YoY Change	-75.48%	-84.4%
FREE CASH FLOW
Cash From Operating Activities	-$40.71K	-$212.2K	-$66.45K
Capital Expenditures	-$3.830K	-$30.00K	-$19.95K
Free Cash Flow	-$36.88K	-$182.2K	-$46.50K
YoY Change	-20.69%	-65.77%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	1462 Rudder Lane
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Knoxville
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001584693
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
CY2022Q3	HITC	Common Stock Subscribed CommonStockSubscribed		usd
CY2022Q3	HITC	Stock Subscription Receivables StockSubscriptionReceivables		usd
CY2022	HITC	Derivative Expense DerivativeExpense		usd
CY2022	HITC	Debt Forgiveness DebtForgiveness		usd
CY2022	HITC	Lawsuit Settlements LawsuitSettlements		usd
CY2022	HITC	Stock Issued During Period Value New Issues Issuance Of Shares Under Debt Settlement And Amendment Agreement StockIssuedDuringPeriodValueNewIssuesIssuanceOfSharesUnderDebtSettlementAndAmendmentAgreement		usd
CY2022	HITC	Derivative Expense DerivativeExpense		usd
CY2022	HITC	Debt Forgiveness DebtForgiveness		usd
CY2022	HITC	Lawsuit Settlements LawsuitSettlements		usd
CY2021	HITC	Repayments Of Short Term Debt Excluding Related Party Debt RepaymentsOfShortTermDebtExcludingRelatedPartyDebt		usd
CY2021	HITC	Issuance Of Warrants With Debt Recorded As Debt Discount IssuanceOfWarrantsWithDebtRecordedAsDebtDiscount		usd
CY2022	HITC	Capital Expenditures Included In Accounts Payable And Accrued Expenses CapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses		usd
CY2022	us-gaap	Stock Issued1 StockIssued1		usd
CY2022	HITC	Issuance Of Common Stock For Payment Of Convertible Debt IssuanceOfCommonStockForPaymentOfConvertibleDebt		usd
CY2022	HITC	Issuance Of Common Stock For Payment Of Items Included In Accounts Payable And Accrued Expenses IssuanceOfCommonStockForPaymentOfItemsIncludedInAccountsPayableAndAccruedExpenses		usd
CY2022	HITC	Issuance Of Debt For Purchase And Cancellation Of Shares IssuanceOfDebtForPurchaseAndCancellationOfShares		usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent		usd
CY2021Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent		usd
CY2020Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate		pure
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate		pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-07-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--07-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-36564
CY2022	dei	Entity Registrant Name EntityRegistrantName	Healthcare Integrated Technologies, Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-1173741
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	TN
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	37919
CY2022	dei	City Area Code CityAreaCode	(865)
CY2022	dei	Local Phone Number LocalPhoneNumber	719-8160
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q1	dei	Entity Public Float EntityPublicFloat	4230467	usd
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	42304673	shares
CY2022	dei	Auditor Firm AuditorFirmId	910
CY2022	dei	Auditor Name AuditorName	Rodefer Moss & Co, PLLC
CY2022	dei	Auditor Location AuditorLocation	Brentwood, Tennessee
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1051	usd
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11443	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	36616	usd
CY2021Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	37575	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	37667	usd
CY2021Q3	us-gaap	Assets Current AssetsCurrent	49018	usd
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	232	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	688353	usd
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	440897	usd
CY2022Q3	us-gaap	Assets Assets	726020	usd
CY2021Q3	us-gaap	Assets Assets	490147	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	202973	usd
CY2021Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	191542	usd
CY2022Q3	HITC	Accounts Payable And Accrued Expense Related Party AccountsPayableAndAccruedExpenseRelatedParty	641315	usd
CY2021Q3	HITC	Accounts Payable And Accrued Expense Related Party AccountsPayableAndAccruedExpenseRelatedParty	252440	usd
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1452434	usd
CY2021Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1152218	usd
CY2022Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	325000	usd
CY2021Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	325000	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	455605	usd
CY2021Q3	us-gaap	Notes Payable Current NotesPayableCurrent	230000	usd
CY2022Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	76451	usd
CY2021Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	108232	usd
CY2022Q3	us-gaap	Liabilities Liabilities	3153778	usd
CY2021Q3	us-gaap	Liabilities Liabilities	2259432	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	42304673	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	42304673	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40118007	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40118007	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	42305	usd
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	40118	usd
CY2022Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	11839645	usd
CY2021Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	11039284	usd
CY2021Q3	HITC	Common Stock Subscribed CommonStockSubscribed	200000	usd
CY2021Q3	HITC	Stock Subscription Receivables StockSubscriptionReceivables	-100000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14309708	usd
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12948687	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-2427758	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-1769285	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	726020	usd
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	490147	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1138065	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1274634	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1138065	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	1274634	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1138065	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-1274634	usd
CY2022	us-gaap	Interest Expense InterestExpense	447623	usd
CY2021	us-gaap	Interest Expense InterestExpense	227900	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	224667	usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	89669	usd
CY2021	HITC	Derivative Expense DerivativeExpense	97201	usd
CY2021	HITC	Debt Forgiveness DebtForgiveness	41931	usd
CY2021	HITC	Lawsuit Settlements LawsuitSettlements	13110	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-222956	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-180391	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1361021	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1455025	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42024810	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37377106	shares
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	-1842198	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1455025	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	255000	usd
CY2021	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-50000	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	200000	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	317530	usd
CY2021	HITC	Stock Issued During Period Value Issuance Of Shares For Payment Of Accounts Payable StockIssuedDuringPeriodValueIssuanceOfSharesForPaymentOfAccountsPayable	5000	usd
CY2021	HITC	Stock Subscriptions StockSubscriptions	200000	usd
CY2021	HITC	Stock Subscriptions Receivable StockSubscriptionsReceivable	100000	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	700408	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-1769285	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1361021	usd
CY2022	HITC	Receipt Of Cash Under Stock Subscription Agreement ReceiptOfCashUnderStockSubscriptionAgreement	-25000	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	25500	usd
CY2022	HITC	Stock Issued During Period Value New Issuance Of Shares And Settlement Of Stock Subscription StockIssuedDuringPeriodValueNewIssuanceOfSharesAndSettlementOfStockSubscription	50000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	99905	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	552143	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-2427758	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1361021	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1455025	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	11215	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	8571	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	473511	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	621776	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	25500	usd
CY2021	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1690	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	374395	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	180000	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	224667	usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	89669	usd
CY2021	HITC	Derivative Expense DerivativeExpense	97201	usd
CY2021	HITC	Debt Forgiveness DebtForgiveness	41931	usd
CY2021	HITC	Lawsuit Settlements LawsuitSettlements	13110	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-959	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-9363	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	11431	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	18933	usd
CY2022	HITC	Accounts Payables And Accrued Expense Related Party AccountsPayablesAndAccruedExpenseRelatedParty	323400	usd
CY2021	HITC	Accounts Payables And Accrued Expense Related Party AccountsPayablesAndAccruedExpenseRelatedParty	50150	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	153100	usd
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	19859	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-212177	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-592192	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	32690	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	60608	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-32690	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-60608	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	255000	usd
CY2022	HITC	Proceeds From Common Stock Subscriptions ProceedsFromCommonStockSubscriptions	25000	usd
CY2021	HITC	Proceeds From Common Stock Subscriptions ProceedsFromCommonStockSubscriptions	100000	usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	504000	usd
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	300700	usd
CY2022	HITC	Repayments Of Short Term Debt Excluding Related Party Debt RepaymentsOfShortTermDebtExcludingRelatedPartyDebt	360000	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	213600	usd
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	26127	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	148125	usd
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	95656	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	234475	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	586171	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-10392	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-66629	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11443	usd
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	78072	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1051	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11443	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	51180	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	17806	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	147117	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	271340	usd
CY2022	HITC	Capital Expenditures From Stockbased Compensation CapitalExpendituresFromStockbasedCompensation	78632	usd
CY2021	HITC	Capital Expenditures From Stockbased Compensation CapitalExpendituresFromStockbasedCompensation	78632	usd
CY2022	HITC	Derivative Liability Recorded As Debt Discount DerivativeLiabilityRecordedAsDebtDiscount	192886	usd
CY2021	HITC	Derivative Liability Recorded As Debt Discount DerivativeLiabilityRecordedAsDebtDiscount	100700	usd
CY2022	HITC	Issuance Of Warrants With Debt Recorded As Debt Discount IssuanceOfWarrantsWithDebtRecordedAsDebtDiscount	99905	usd
CY2021	HITC	Capital Expenditures Included In Accounts Payable And Accrued Expenses CapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses	2710	usd
CY2021	us-gaap	Stock Issued1 StockIssued1	200000	usd
CY2021	HITC	Issuance Of Common Stock For Payment Of Convertible Debt IssuanceOfCommonStockForPaymentOfConvertibleDebt	275000	usd
CY2021	HITC	Issuance Of Common Stock For Payment Of Items Included In Accounts Payable And Accrued Expenses IssuanceOfCommonStockForPaymentOfItemsIncludedInAccountsPayableAndAccruedExpenses	45841	usd
CY2021	HITC	Issuance Of Debt For Purchase And Cancellation Of Shares IssuanceOfDebtForPurchaseAndCancellationOfShares	50000	usd
CY2021Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8923	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8923	usd
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8691	usd
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	232	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1361021	usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	89669	usd
CY2022Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	76451	usd
CY2021Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	108232	usd
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zLH9IdQyOdxi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_z2XinZSgIYWf">Reclassifications</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior period amounts have been reclassified to conform to current period presentation with no changes to previously reported net loss or stockholders’ deficit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_ztqSvlQJJDOg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zjzQ9EzcwjZd">Risk and Uncertainties</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Factors that could affect our future operating results and cause actual results to vary materially from management’s expectation include, but are not limited to: our ability to maintain and secure adequate capital to fund our operations and fully develop our product(s); our ability to source strong opportunities with sufficient risk adjusted returns; acceptance of the terms and conditions of our licenses and/or the acceptance of our royalties and fees; the nature and extent of competition from other companies that may reduce market share and create pressure on pricing and investment return expectations; changes in the projects in which we plan to invest which result from factors beyond our control, including, but not limited to, a change in circumstances, capacity and economic impacts; changes in laws, regulations, accounting, taxation, and other requirements affecting our operations and business. Negative developments in these or other risk factors could have a significant adverse effect on our financial position, results of operations and cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus originating in Wuhan, China (the “COVID-19 outbreak”) and the risks to the international community as the virus spreads globally beyond its point of origin. In March 2020, the WHO classified the COVID-19 outbreak as a pandemic, based on the rapid increase in exposure globally. The full impact of the COVID-19 outbreak continues to evolve as of the date of this report. As such, it is uncertain as to the full magnitude that the pandemic will have on the Company’s future financial condition, liquidity, and results of operations. Management is actively monitoring the impact of the global situation on its financial condition, liquidity, operations, suppliers, industry, and workforce. Given the daily evolution of the COVID-19 outbreak and the global responses to curb its spread, the Company is not able to estimate the effects of the COVID-19 outbreak on its results of operations, financial condition, or liquidity for fiscal year 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_znzmsbyJ4eme" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zUqTCL8XkW04">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates. We base our estimates on experience and various other assumptions that are believed to be reasonable under the circumstances. We evaluate our estimates and assumptions on a regular basis and actual results may differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	us-gaap	Depreciation Depreciation	232	usd
CY2021	us-gaap	Depreciation Depreciation	2221	usd
CY2022Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	202973	usd
CY2021Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	191542	usd
CY2022Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	267765	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	7256	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	6890	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	6890	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	6890	usd
CY2022Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	76451	usd
CY2021Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	108232	usd
CY2021Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	202290	usd
CY2022Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	373550	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	36535	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	5297	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	6890	usd
CY2021Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	50150	usd
CY2022Q3	HITC	Accounts Payable And Accrued Expenses Related Party AccountsPayableAndAccruedExpensesRelatedParty	641315	usd
CY2021Q3	HITC	Accounts Payable And Accrued Expenses Related Party AccountsPayableAndAccruedExpensesRelatedParty	252440	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8923	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-17333	usd
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-6350	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	688353	usd
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	440897	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10983	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6350	usd
CY2022	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P19Y
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	94434	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	129250	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	119725	usd
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	130340	usd
CY2022Q3	us-gaap	Interest Payable Current InterestPayableCurrent	83248	usd
CY2021Q3	us-gaap	Interest Payable Current InterestPayableCurrent	61202	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	844288	usd
CY2021Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	443982	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	224667	usd
CY2022Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1440364	usd
CY2021Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1140148	usd
CY2022Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	12070	usd
CY2021Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	12070	usd
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1452434	usd
CY2021Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1152218	usd
CY2022Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	975000	usd
CY2021Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	735000	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	194395	usd
CY2021Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	180000	usd
CY2022Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	780605	usd
CY2021Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	555000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	147085	usd
CY2021Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	108232	usd
CY2022	HITC	Derivative Liability On Issuance Of Note DerivativeLiabilityOnIssuanceOfNote	192886	usd
CY2021	HITC	Derivative Liability On Issuance Of Note DerivativeLiabilityOnIssuanceOfNote	197901	usd
CY2022Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	76451	usd
CY2021Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	108232	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	224667	usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	89669	usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.21	pure
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-238994	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-305555	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	750	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	115950	usd
CY2022	HITC	Income Tax Reconciliation Derivatives IncomeTaxReconciliationDerivatives	-31443	usd
CY2021	HITC	Income Tax Reconciliation Derivatives IncomeTaxReconciliationDerivatives	-12155	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	91095	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	144992	usd
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	506	usd
CY2021	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	573	usd
CY2022Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	773851	usd
CY2021Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	682756	usd
CY2022Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	773851	usd
CY2021Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	682756	usd
CY2022Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	3590000	usd
CY2022	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	expiring in fiscal 2037
CY2022Q3	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2021Q3	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2022Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2021Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	267765	usd
CY2021Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	202290	usd
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	42304673	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40118007	shares
CY2021Q3	HITC	Stock Subscription Receivables StockSubscriptionReceivables	-100000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.7161	pure
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y3M
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0020	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	200000	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	300000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	100000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	100000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	100000	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	200000	shares

Files In Submission

Name	View Source	Status
0001493152-22-026689-index-headers.html	Edgar Link	pending
0001493152-22-026689-index.html	Edgar Link	pending
0001493152-22-026689.txt	Edgar Link	pending
0001493152-22-026689-xbrl.zip	Edgar Link	pending
ex10-6.htm	Edgar Link	pending
ex10-6_001.jpg	Edgar Link	pending
ex10-6_002.jpg	Edgar Link	pending
ex10-6_003.jpg	Edgar Link	pending
ex10-6_004.jpg	Edgar Link	pending
ex10-6_005.jpg	Edgar Link	pending
ex10-6_006.jpg	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
hitc-20220731.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
hitc-20220731_def.xml	Edgar Link	unprocessable
hitc-20220731_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
hitc-20220731_cal.xml	Edgar Link	unprocessable
hitc-20220731_lab.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HITC
Healthcare Integrated Technologies Inc. Stock $hitc

2022 Q3 Form 10-K Financial Statement

#000149315222026689 Filed on September 23, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HITC Healthcare Integrated Technologies Inc. Stock $hitc

2022 Q3 Form 10-K Financial Statement

#000149315222026689 Filed on September 23, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HITC
Healthcare Integrated Technologies Inc. Stock $hitc